NCT01763047View on ClinicalTrials.gov

Evaluation of the Performance of Investigational Contact Lenses in a Presbyopic Population

NACompletedINTERVENTIONAL
Enrollment

298

Participants

Timeline

Start Date

November 30, 2012

Primary Completion Date

February 28, 2013

Study Completion Date

February 28, 2013

Conditions
Presbyopia
Interventions
DEVICE

etafilcon A

To be worn in a daily wear modality for a minimum of 6 hours per day.

DEVICE

lotrafilcon B

Lenses will be worn in a reuseable modality; cleaned and disinfected each night.

Trial Locations (19)

Unknown

Mission Viejo

RPS, Jacksonville

Jacksonville

Saint Augustine

Tallahassee

Winter Park

Roswell

Lutherville

Closter

New York

Denver

Athens

Kingston

Warwick

Memphis

Amarillo

Tyler

Salt Lake City

Salem

All Listed Sponsors
lead

Johnson & Johnson Vision Care, Inc.

INDUSTRY

NCT01763047 - Evaluation of the Performance of Investigational Contact Lenses in a Presbyopic Population | Biotech Hunter | Biotech Hunter